Rennovia
Rennovia was a Menlo Park-based chemical process technology developer founded in 2009, focused on cost reduction versus incumbent petrochemical processes. It raised approximately $78.5 million in private funding between 2009 and 2014 before apparently ceasing independent operations.
- Company typePrivate
- Founded2009
- HeadquartersMenlo Park, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Rennovia does
Rennovia was a chemical process technology development company headquartered in Menlo Park, California, founded in 2009. According to firmographic data, the firm focused on developing process technologies aimed at reducing production costs relative to incumbent petrochemical manufacturing routes. The company operated as a for-profit private entity with a headcount in the 11-50 range, positioning itself as a technology development venture in the industrial chemistry sector rather than a commercial-scale chemicals producer.
The company raised approximately $78.5 million across multiple funding rounds between 2009 and 2014, with the earliest round backed by 5AM Ventures and Versant Ventures. Subsequent rounds in 2013 and 2014 collectively added roughly $59.7 million of additional capital, though investor identities for those later rounds were not disclosed. No specific products, customer relationships, partnerships, management team details, or revenue figures are available in the source data, limiting visibility into the company's commercial progress and the specific process chemistries it pursued.
The company's current operating status is uncertain and indicative of cessation. The rennovia.com domain is currently listed for sale on HugeDomains for $4,695, strongly suggesting the company has wound down independent operations. No official acquisition, merger, or formal shutdown announcement was identified in available sources, leaving a significant diligence gap regarding the company's ultimate disposition, IP ownership, and any successor entity.
Rennovia firmographics
Firmographics- Name
- Rennovia
- Website
- https://rennovia.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Closed
- Headcount range
- 11–50 employees
- Short description
- Rennovia was a Menlo Park-based chemical process technology developer founded in 2009, focused on cost reduction versus incumbent petrochemical processes. It raised approximately $78.5 million in private funding between 2009 and 2014 before apparently ceasing independent operations.
- Ownership category
- akta.pro rank
Rennovia industry classification
Industry- Product category
- Industrial Chemical Process Technology
- NAICS
- Other Basic Organic Chemical Manufacturing (32519), Basic Chemical Manufacturing (3251)
- SIC
- Industrial Organic Chemicals (2860), Miscellaneous Chemical Products (2890)
- akta.pro primary industry
- C1 & Synthesis Gas Derivatives (Methanol, Formaldehyde, Acetic Acid) (IMAEADAC)
- akta.pro secondary industry
- Industrial & Process Engineering Consulting (BPAHAIAF)
Keywords
Where Rennovia is headquartered
LocationHeadquarters
- HQ city
- Menlo Park
- HQ country
- United States
- HQ region
- North America
Markets served
Rennovia business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Technology or R&D, Personnel, Operations
Rennovia product offering
Product offeringCore offering
Rennovia develops proprietary chemical process technologies aimed at reducing manufacturing costs versus conventional petrochemical-based routes. The company's work targets industrial chemical production, with public references indicating involvement in process routes relevant to adipic acid and related nylon 6,6 intermediates. The firm operated as a process technology development company rather than a bulk chemical manufacturer.
Differentiator
Problem solved
Functional benefit
Companies that use Rennovia
Customer profileIdeal customer profiles1 record
Rennovia technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Rennovia partnerships and signals
Strategic signalRecent moves6 records
Expansion highlights2 records
Rennovia competitors and assessment
Company assessmentOthers
- Cargill: Cargill supplies bio-based feedstocks (e.g., corn-derived glucose) and operates in bio-based chemical ventures (including a previous bio-based 3PD/PDO business). It is an enabling/ecosystem player that supplies the renewable carbon inputs underpinning Rennovia-type bio-process chemistry.
Broad incumbents
- BASF: BASF is the world's largest chemical producer and a major player in adipic acid, hexamethylenediamine, and nylon 6,6 intermediates — the very markets Rennovia targets. It is the principal incumbent whose petrochemical processes Rennovia's bio-based technology aims to undercut.
- INVISTA: INVISTA is a leading global producer of adipic acid, hexamethylenediamine, and nylon intermediates, and the largest integrated nylon 6,6 value chain participant. Represents the dominant petrochemical benchmark against which any Rennovia bio-based process must compete on cost.
- Novozymes: Novozymes is the global leader in industrial enzymes and microbial solutions used in chemical and bio-based manufacturing processes. Relevant as a broad incumbent supplying the type of biological catalysts Rennovia's process technology relies on.
Direct peers
- Verdezyne: Verdezyne used engineered yeast strains to produce bio-based adipic acid — directly competing with Rennovia's own bio-adipic acid process target. Same feedstock strategy, same target molecule, same renewable-versus-petrochemical displacement thesis.
- BioAmber: BioAmber developed bio-based succinic acid process technology as a renewable alternative to petrochemical routes, and similarly pursued licensing and joint-venture models with chemical producers. Comparable in technology and target chemistry applications to Rennovia.
- Amyris: Amyris uses synthetic biology to produce renewable specialty ingredients and chemical intermediates historically derived from petroleum. Both target displacement of petrochemical-derived products with bio-based alternatives via proprietary microbial/catalytic processes.
- Codexis: Codexis engineers enzymes and biocatalysts used in industrial chemical manufacturing processes, including pharmaceutical and chemical intermediates. Both companies commercialize catalytic IP into existing chemical manufacturing assets, sharing a process-technology licensing go-to-market against petrochemical incumbents.
- Genomatica: Genomatica develops bio-based process technology for producing widely-used chemicals (e.g., butanediol) from renewable feedstocks via proprietary catalysts and microbes. It is the closest direct analog to Rennovia, with the same bio-routing strategy against incumbent petrochemical processes and a similar licensing-oriented business model.
Emerging players
- Myriant (now GC Innovation America): Myriant developed bio-based succinic acid using fermentation routes and pursued commercial offtake with chemical manufacturers. Operates in the same bio-based chemical intermediate space, though its target molecule differs from Rennovia's adipic acid focus.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat1 record
Key risks6 records
Key highlights5 records
Customer concentration
Rennovia social profiles
Digital presenceRennovia financial estimates
Financial estimateRevenue estimate
Valuation estimate
Rennovia leadership team
Management profileNumber of profiles
Rennovia funding detail
Funding detailFunding overview
Funding rounds5 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Rennovia M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Rennovia
What does Rennovia do?
Rennovia develops proprietary chemical process technologies aimed at reducing manufacturing costs versus conventional petrochemical-based routes. The company's work targets industrial chemical production, with public references indicating involvement in process routes relevant to adipic acid and related nylon 6,6 intermediates. The firm operated as a process technology development company rather than a bulk chemical manufacturer.
When was Rennovia founded?
Rennovia was founded in 2009. It employs 11 to 50 people.
Where is Rennovia based?
Rennovia is headquartered in Menlo Park, United States, in the North America region.
Who are Rennovia's main competitors?
Cargill is listed as an others. Broad incumbents are BASF, INVISTA and Novozymes. Direct peers are Verdezyne, BioAmber, Amyris, Codexis and Genomatica. Myriant (now GC Innovation America) is listed as an emerging player.
Does Rennovia have an API?
No public API is recorded for Rennovia.
What industry is Rennovia in?
Rennovia's product category is Industrial Chemical Process Technology. Its primary akta.pro industry code is IMAEADAC, C1 & Synthesis Gas Derivatives (Methanol, Formaldehyde, Acetic Acid), with a secondary code of BPAHAIAF, Industrial & Process Engineering Consulting. Its NAICS code is 32519 and its SIC code is 2860.